Funan Liu

1.8k total citations · 1 hit paper
54 papers, 1.3k citations indexed

About

Funan Liu is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Funan Liu has authored 54 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 20 papers in Genetics and 18 papers in Oncology. Recurrent topics in Funan Liu's work include Virus-based gene therapy research (19 papers), Cancer Research and Treatments (14 papers) and RNA Interference and Gene Delivery (11 papers). Funan Liu is often cited by papers focused on Virus-based gene therapy research (19 papers), Cancer Research and Treatments (14 papers) and RNA Interference and Gene Delivery (11 papers). Funan Liu collaborates with scholars based in China, United States and Türkiye. Funan Liu's co-authors include Zhenguo Cheng, Zhenning Wang, Hanwei Huang, Huimian Xu, Mengchi Sun, Feng Li, Yanshu Li, Jin Sun, Zhe Sun and Zhonggui He and has published in prestigious journals such as Cell, Advanced Materials and Nature Communications.

In The Last Decade

Funan Liu

49 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Coacervate vesicles assembled by liquid–liquid phase separation improve delivery of biopharmaceuticals

2025 31 citations Hanwei Huang, Ruizhe Zhang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Funan Liu China	20	613	302	265	198	187	54	1.3k
Baofeng Guo China	19	513 0.8×	185 0.6×	329 1.2×	95 0.5×	138 0.7×	57	1.1k
Yuge Zhao China	22	524 0.9×	153 0.5×	416 1.6×	168 0.8×	110 0.6×	37	1.2k
Hassan Dianat‐Moghadam Iran	20	414 0.7×	356 1.2×	227 0.9×	64 0.3×	111 0.6×	43	1.0k
Nadezhda V. Koshkina United States	27	597 1.0×	353 1.2×	264 1.0×	581 2.9×	126 0.7×	39	1.5k
Roghayyeh Baghban Iran	13	807 1.3×	532 1.8×	351 1.3×	168 0.8×	60 0.3×	22	1.7k
Shibing Wang China	24	721 1.2×	540 1.8×	201 0.8×	79 0.4×	456 2.4×	78	1.5k
Anabel Sorolla Spain	22	791 1.3×	262 0.9×	144 0.5×	81 0.4×	100 0.5×	49	1.3k
Leiming Xu China	17	362 0.6×	193 0.6×	258 1.0×	118 0.6×	54 0.3×	43	1.0k
Jiwu Wei China	25	941 1.5×	527 1.7×	186 0.7×	183 0.9×	381 2.0×	59	1.9k
Qin Liu China	22	593 1.0×	468 1.5×	370 1.4×	101 0.5×	59 0.3×	62	1.5k

Countries citing papers authored by Funan Liu

Since Specialization

Citations

This map shows the geographic impact of Funan Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Funan Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Funan Liu more than expected).

Fields of papers citing papers by Funan Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Funan Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Funan Liu. The network helps show where Funan Liu may publish in the future.

Co-authorship network of co-authors of Funan Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Funan Liu. A scholar is included among the top collaborators of Funan Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Funan Liu. Funan Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Xu, Liting Chen, Guangna Liu, et al.. (2025). Tailoring an intravenously injectable oncolytic virus for augmenting radiotherapy. Cell Reports Medicine. 6(5). 102078–102078. 4 indexed citations

Chen, Liting, Guanyu Qiao, Funan Liu, Keman Cheng, & Xiao Zhao. (2025). Chemical engineering of bacterial outer membrane vesicles for disease treatment: strategies and applications. Science China Chemistry. 68(12). 6160–6170.

Chen, Liting, Xu Chen, Xu H, et al.. (2024). RVG29-modified oncolytic herpes simplex virus for intracranial tumor treatment. Nano Today. 61. 102573–102573. 1 indexed citations

Li, Yuling, et al.. (2024). COVID-19 and the risk of acute cardiovascular diseases: a two-sample Mendelian randomization study. BMC Cardiovascular Disorders. 24(1). 389–389.

Liu, Mingyang, Hu Wu, Boshu Ouyang, et al.. (2024). Augmenting Tumor Lysis and Immune Response through HIFU-armed Oncolytic Virus Delivery System. Nano Today. 61. 102571–102571. 2 indexed citations

Liu, Funan, Jifang Gong, Zhaoyu Jin, et al.. (2024). Safety and efficacy results from the phase I/IIa study of FG-M108 plus CAPOX as first-line (1L) treatment for patients with CLDN18.2+/HER2- locally advanced unresectable or metastatic gastric or gastroesophageal junction (G/GEJ) adenocarcinoma.. Journal of Clinical Oncology. 42(16_suppl). 4049–4049. 3 indexed citations

Hou, Xiaoyu, Mingyang Liu, Hu Wu, et al.. (2024). Differential releasing hydrogel loaded with oncolytic viruses and anti-CAFs drug to enhance oncology therapeutic efficacy. Chinese Chemical Letters. 36(5). 110106–110106.

Wu, Hu, Mingyang Liu, Xu H, et al.. (2024). Tumor cell membrane biomimetic liposomes-coated oncolytic viruses to target the homotypic tumor and augment the antitumor efficacy. Chinese Chemical Letters. 36(7). 110493–110493. 3 indexed citations

Ning, Weihai, Funan Liu, Yuduo Guo, et al.. (2024). Non-secreting IL12 expressing oncolytic adenovirus Ad-TD-nsIL12 in recurrent high-grade glioma: a phase I trial. Nature Communications. 15(1). 9299–9299. 9 indexed citations

10.

Liu, Mingyang, Ruizhe Zhang, Hanwei Huang, et al.. (2023). Erythrocyte‐Leveraged Oncolytic Virotherapy (ELeOVt): Oncolytic Virus Assembly on Erythrocyte Surface to Combat Pulmonary Metastasis and Alleviate Side Effects. Advanced Science. 11(5). e2303907–e2303907. 13 indexed citations

11.

Huang, Hanwei, Mingyang Liu, Mengchi Sun, et al.. (2023). Virus-Protein Corona Replacement Strategy to Improve the Antitumor Efficacy of Intravenously Injected Oncolytic Adenovirus. ACS Nano. 17(15). 14461–14474. 15 indexed citations

12.

Huang, Hanwei, Mengchi Sun, Ruizhe Zhang, et al.. (2023). Inhibition of Tumor Metastasis by Liquid‐Nitrogen‐Shocked Tumor Cells with Oncolytic Viruses Infection (Adv. Mater. 28/2023). Advanced Materials. 35(28). 9 indexed citations

13.

Pan, Siwei, Jiaming Zhu, Pengfei Liu, et al.. (2023). FN1 mRNA 3'-UTR supersedes traditional fibronectin 1 in facilitating the invasion and metastasis of gastric cancer through the FN1 3'-UTR-let-7i-5p-THBS1 axis. Theranostics. 13(14). 5130–5150. 17 indexed citations

14.

Chen, Liting, Xu Chen, Defang Ouyang, et al.. (2023). Progress in oncolytic viruses modified with nanomaterials for intravenous application. Cancer Biology and Medicine. 20(11). 1–26. 17 indexed citations

15.

Huang, Hanwei, et al.. (2022). Emerging systemic delivery strategies of oncolytic viruses: A key step toward cancer immunotherapy. Nano Research. 15(5). 4137–4153. 56 indexed citations

16.

Ouyang, Boshu, Funan Liu, Shuangrong Ruan, et al.. (2019). Localized Free Radicals Burst Triggered by NIR-II Light for Augmented Low-Temperature Photothermal Therapy. ACS Applied Materials & Interfaces. 11(42). 38555–38567. 76 indexed citations

17.

Zhang, Jiliang, Shaojuan Zhang, Meng Su, et al.. (2018). Combined CB2 receptor agonist and photodynamic therapy synergistically inhibit tumor growth in triple negative breast cancer. Photodiagnosis and Photodynamic Therapy. 24. 185–191. 20 indexed citations

18.

Cheng, Zhenguo, et al.. (2015). CREB is a key negative regulator of carbonic anhydrase IX (CA9) in gastric cancer. Cellular Signalling. 27(7). 1369–1379. 14 indexed citations

19.

Jiang, Chenggang, Yan Xu, Zhenning Wang, et al.. (2010). Clinicopathological analysis and prognostic significance of peritoneal cytology in Chinese patients with advanced gastric cancer. ANZ Journal of Surgery. 81(9). 608–613. 11 indexed citations

20.

Di, Na, Funan Liu, Zhi‐Feng Miao, Zongmin Du, & Huimian Xu. (2009). Destruction of gastric cancer cells to mesothelial cells by apoptosis in the early peritoneal metastasis. Journal of Huazhong University of Science and Technology [Medical Sciences]. 29(2). 163–168. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact